Moderna

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
2,700
Employees2,700
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
2,700
Employees2,700

MRNA Key Statistics

Market cap
70.74B
Market cap70.74B
Price-Earnings ratio
6.68
Price-Earnings ratio6.68
Dividend yield
Dividend yield
Average volume
3.31M
Average volume3.31M
High today
$185.74
High today$185.74
Low today
$177.10
Low today$177.10
Open price
$184.67
Open price$184.67
Volume
2.25M
Volume2.25M
52 Week high
$321.31
52 Week high$321.31
52 Week low
$115.03
52 Week low$115.03

MRNA News

Yahoo Finance 1d
Moderna Receives FDA Emergency Use Authorization for Omicron-Targeting Bivalent COVID-19 Booster Vaccine in Children 6 Months Through 5 Years of Age - Yahoo Finance

mRNA-1273.222 Targets the BA.4/BA.5 Strains of Omicron Variant Authorization Is Based Upon Clinical and Pre-Clinical Data for Moderna's Bivalent Vaccines CAMB...

Moderna Receives FDA Emergency Use Authorization for Omicron-Targeting Bivalent COVID-19 Booster Vaccine in Children 6 Months Through 5 Years of Age - Yahoo Finance
Yahoo Finance 2d
Brad Miller Joins Moderna as Chief Information Officer - Yahoo Finance

Current Chief Digital Officer, Marcello Damiani, to retire in March CAMBRIDGE, MA / ACCESSWIRE / December 7, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnolog...

Brad Miller Joins Moderna as Chief Information Officer - Yahoo Finance
Investor's Business Daily 2d
Moderna Stock Is Yo-Yoing On New Omicron Booster Data — Is It A Buy?

Moderna stock is yo-yoing in December after unveiling the first human data from its new bivalent Covid booster shot. X The company said its bivalent booster v...

Moderna Stock Is Yo-Yoing On New Omicron Booster Data — Is It A Buy?

Analyst ratings

50%

of 20 ratings
Buy
50%
Hold
50%
Sell
0%

MRNA Earnings

$0.00
$3.76
$7.53
$11.29
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market

More MRNA News

Yahoo Finance 3d
Moderna shareholders have earned a 111% CAGR over the last three years - Yahoo Finance

Investing can be hard but the potential fo an individual stock to pay off big time inspires us. You won't get it right every time, but when you do, the returns...

Moderna shareholders have earned a 111% CAGR over the last three years - Yahoo Finance
Yahoo Finance 4d
Should Investors Buy Pfizer & Moderna Stock for 2023? - Yahoo Finance

Much of the social and economic post-pandemic recovery is accredited to Covid-19 vaccine makers Pfizer PFE and Moderna MRNA. Investors may be wondering if these...

Should Investors Buy Pfizer & Moderna Stock for 2023? - Yahoo Finance
Yahoo Finance 4d
UPDATE 2-Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents - Yahoo Finance

(Adds context, Pfizer comment) By Blake Brittain Dec 5 (Reuters) - Pfizer Inc and its German partner, BioNTech SE, fired back at Moderna Inc on Monday in a pa...

UPDATE 2-Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents - Yahoo Finance
Reuters 4d
UPDATE 1-Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5

(Adds details and background) Dec 5 (Reuters) - Pfizer Inc and its German partner BioNTech SE said on Monday they have submitted an application to the U.S. Foo...

UPDATE 1-Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.